Search results
Dan Wechsler. CEO of Melinta Therapeutics, through IPO: NASDAQ (MLNT) CEO of SmileBrands, a Welsh Carson Portfolio Company with over 600MM revenue, through sale to Gryphon Investors. Global President of Bausch and Lomb, a Warburg Pincus portfolio company, through sale to Valeant Pharmaceuticals for $9.3B.
Dan WECHSLER, Professor, Director of Pediatric Oncology | Cited by 2,868 | of Emory University, GA (EU) | Read 135 publications | Contact Dan WECHSLER
Dan Wechsler, M.D., Ph.D., Director of Pediatric Oncology at Aflac Cancer & Blood Disorders Center of Children’s Healthcare of Atlanta and Professor of Pediatrics at Emory University School of Medicine, had a passion for interest in cancer research that started when he was in college.
Dan Wechsler. An Independent producer since 2003, Dan Wechsler holds a master degree in business management from the High School of Economics in Lausanne. In 2003, he was admitted to the European Mega Media program and completed his studies at Eurimages under the auspices of the Council of Europe.
A native New Yorker, Dan Wechsler is a rare bookseller, publisher and filmmaker. His documentary MORE THAN THE RAINBOW premiered at DOC NYC in 2012 and later screened as the opening night film at the Coney Island Film Festival where it won the award for Best Documentary.
Dan Wechsler, a seasoned Healthcare executive with 28 years of experience, has joined BSIP as a partner leading Healthcare investments. In addition to BSIP, Dan serves as the Executive Chairman of Navaderm, a BelHealth Partners investment focused on Dermatology.
A board-certified pediatric oncologist, he specializes in the treatment of childhood leukemia. Dr. Wechsler is a member of the Discovery and Developmental Therapeutics Research Program at Winship Cancer Institute of Emory University.
